Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.81 USD
−42.21 M USD
0.00 USD
17.10 M
About Pulse Biosciences, Inc
Sector
Industry
CEO
Burke T. Barrett
Website
Headquarters
Hayward
Founded
2014
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PLSE is 20.52 USD — it has decreased by −2.43% in the past 24 hours. Watch Pulse Biosciences, Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pulse Biosciences, Inc stocks are traded under the ticker PLSE.
PLSE stock has risen by 15.87% compared to the previous week, the month change is a 20.48% rise, over the last year Pulse Biosciences, Inc has showed a 120.59% increase.
PLSE reached its all-time high on Feb 8, 2021 with the price of 45.82 USD, and its all-time low was 1.18 USD and was reached on Aug 30, 2022. View more price dynamics on PLSE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PLSE stock is 4.12% volatile and has beta coefficient of 3.56. Track Pulse Biosciences, Inc stock price on the chart and check out the list of the most volatile stocks — is Pulse Biosciences, Inc there?
Today Pulse Biosciences, Inc has the market capitalization of 1.28 B, it has decreased by −3.12% over the last week.
Yes, you can track Pulse Biosciences, Inc financials in yearly and quarterly reports right on TradingView.
Pulse Biosciences, Inc is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
PLSE earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.24 USD resulting in a 34.85% surprise. The estimated earnings for the next quarter are −0.24 USD per share. See more details about Pulse Biosciences, Inc earnings.
PLSE net income for the last quarter is −12.68 M USD, while the quarter before that showed −11.38 M USD of net income which accounts for −11.39% change. Track more Pulse Biosciences, Inc financial stats to get the full picture.
No, PLSE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 3, 2024, the company has 56.00 employees. See our rating of the largest employees — is Pulse Biosciences, Inc on this list?
Like other stocks, PLSE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pulse Biosciences, Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pulse Biosciences, Inc technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pulse Biosciences, Inc stock shows the buy signal. See more of Pulse Biosciences, Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.